Lifeboat Foundation

What did scientists think about aging in 1931? That’s right. 1931. because that is the year the first biological textbook was published “The Science of Life”. I managed to get my hands on the first edition of this textbook. This was my face when i first received it. As you can see i was quite excited. And this textbook is made up of separate books. I bought book i last year and i read it. Having enjoyed it and discovered that it was part of this massive ensemble piece — well, i’ve read the first “book” — there are, if my roman numerals are correct, 9 books in total. And in this first book, penned “The Living Body”, the authors, most famously, H.G.Wells, Sir Julian Huxley and G.P.Wells, H.G’s son discusses the body as a machine and that.

“For the present it is enough to remember that all animals (including men) are combustion engines of an intricate and curious kind, which live by oxidising their food”

Continue reading “What they thought of aging in 1931” »

Pushing The Boundaries Of Research To Build A Synthetic Kidney — Dr. Andrew McMahon, Ph.D. & Lewis Kleinberg, University Kidney Research Organization (UKRO)

The University Kidney Research Organization (UKRO — https://ukrocharity.org/) is a Los Angeles-based nonprofit charity, co-founded prominent entertainment attorney Kenneth Kleinberg, inspired by his personal journey with kidney disease, focused on supporting medical research and education related to the causes, treatment, and eradication of all forms of kidney disease.

Continue reading “Dr Andrew McMahon & Lewis Kleinberg — Pushing The Boundaries Of Research To Build A Synthetic Kidney” »

‘This doesn’t mean I have become immortal,’ he says. ‘However…’

Omega-3 Fish Oil Gummy Bites provide the brain support and heart health benefits of omega-3 EPA & DHA fatty acids—without the need for large softgels or an aftertaste! What’s not to love about our high-potency tropical-flavored, sugar-free* fish oil gummy bites?

*Not a low-calorie food.

Continue reading “Life Extension” »

That plateau is called “mortality compression”—where the age of death remains relatively fixed. It’s been a consistent phenomenon for folks born up until the 1900s. But according to the study, “mortality postponement”—where the maximum age at death is on the rise—seems to be more common in those born between 1910 and 1950. This means the oldest people born in that timeframe have a solid chance at stretching their years beyond 120.

“As these cohorts attain advanced ages in coming decades, longevity records may increase significantly,” McCarthy says in the news release. “Our results confirm prior work suggesting that if there is a maximum limit to the human lifespan, we are not yet approaching it.”

Smoothing the speed bumps in an important cellular pathway seems to be implicated in ageing.

Taken in pill form, the drug would eliminate cells in the human body that are responsible for advancing the ageing process – potentially doubling our lifespan. But is this desirable?

As long as people have been alive, they’ve wanted to stay alive. But unlike finding the fountain of youth or becoming a vampire, uploading your brain to a computer or the cloud might actually be possible. Theoretically, we already know how to do it, and Elon Musk is even trying a brain implant with Neuralink. But technically, we have a long way to go. We explain the main technological advancements that we’ll need to make whole brain emulation a reality.

MORE TECHNOLOGY VIDEOS:
Why We Still Don’t Have Smart Contact Lenses.

Why We Still Haven’t Cloned Humans — It’s Not Just Ethics.

How Blockchain And Remote Monitoring Can Improve The Healthcare Experience.

Continue reading “What It’ll Take To Upload Our Brains To A Computer” »

Until now, it was unclear as to whether drugs that clear amyloid, which accumulate in the brain during aging and accompany diseases such as Alzheimer’s, have any influence over cognitive decline.

Previous studies have aimed to find this out, but results have been inconclusive due to study designs, hard-to-interpret data, and other issues that muddy the waters. March 10-14th saw the 15th International Conference on Alzheimer’s and Parkinson’s Diseases being held (virtually of course), where Dr. Mark Mintun of Eli Lilly presented data that, at least somewhat, affirmatively answers the question [1].